Innate Pharma S.A. (IPHA)

NASDAQ: IPHA · Real-Time Price · USD

1.790

+0.030 (1.70%)

Jun 4, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
R&D of Pharmaceutical Products	9.01M	20.12M	61.64M	57.67M	24.70M
R&D of Pharmaceutical Products Growth	-55.25%	-67.36%	6.88%	133.47%	-64.60%
Total	9.01M	20.12M	61.64M	57.67M	24.70M
Total Growth	-55.25%	-67.36%	6.88%	133.47%	-64.60%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
France	9.01M	20.12M	61.64M	57.67M	24.70M
France Growth	-55.25%	-67.36%	6.88%	133.47%	-64.60%
Total	9.01M	20.12M	61.64M	57.67M	24.70M
Total Growth	-55.25%	-67.36%	6.88%	133.47%	-64.60%

Source: S&P Global Market Intelligence.